Skip to main content
Top
Gepubliceerd in: Quality of Life Research 4/2011

01-05-2011

Applying area-under-the-curve analysis to enhance interpretation of response profiles: an application to sleep quality scores in patients with fibromyalgia

Auteurs: Andrew G. Bushmakin, Joseph C. Cappelleri, Gergana Zlateva, Alesia Sadosky

Gepubliceerd in: Quality of Life Research | Uitgave 4/2011

Log in om toegang te krijgen
share
DELEN

Deel dit onderdeel of sectie (kopieer de link)

  • Optie A:
    Klik op de rechtermuisknop op de link en selecteer de optie “linkadres kopiëren”
  • Optie B:
    Deel de link per e-mail

Abstract

Purpose

To introduce an application of area-under-the-curve (AUC) that can enrich interpretation of response analysis and illustrate this method on sleep quality scores in patients with fibromyalgia.

Methods

Data were from a 14-week, randomized trial conducted in 750 patients with fibromyalgia treated with placebo or pregabalin (300, 450, or 600 mg/day); sleep quality was assessed daily by the patient using an 11-point numeric rating scale.

Results

Response profiles were implemented for responders who improved (or stayed the same) numerically in sleep quality scores from baseline to week 14 and, separately, for non-responders who worsened (numerically less favorable scores at week 14). Differences between pregabalin and placebo were assessed using an AUC analysis. Improvement in sleep quality was significantly better with pregabalin and can be interpreted as if pregabalin responders improved by 10.8% (300 mg), 14.7% (450 mg), and 19.0% (600 mg) above the placebo responders. Conversely, decrement in sleep quality was worse with placebo and can be interpreted as if placebo non-responders worsened by 3.6% (300 mg), 2.9% (450 mg), and 3.9% (600 mg) over pregabalin non-responders.

Conclusions

The application of an AUC analysis to response profiles for responders and non-responders can enrich the interpretation of sleep quality scores in patients with fibromyalgia. The method can be applied more generally to facilitate and enhance the interpretation of treatment differences on outcomes.
Literatuur
1.
go back to reference Guyatt, G. H., Osoba, D., Wu, A. W., Wyrwich, K. W., & Norman, G. R. (2002). Apr methods to explain the clinical significance of health status measures. Mayo Clinic Proceedings, 77(4), 371–383.PubMedCrossRef Guyatt, G. H., Osoba, D., Wu, A. W., Wyrwich, K. W., & Norman, G. R. (2002). Apr methods to explain the clinical significance of health status measures. Mayo Clinic Proceedings, 77(4), 371–383.PubMedCrossRef
2.
go back to reference Crosby, R. D., Kolotkin, R. L., & Williams, G. R. (2003). May defining clinically meaningful change in health-related quality of life. Journal of Clinical Epidemiology, 56(5), 395–407.PubMedCrossRef Crosby, R. D., Kolotkin, R. L., & Williams, G. R. (2003). May defining clinically meaningful change in health-related quality of life. Journal of Clinical Epidemiology, 56(5), 395–407.PubMedCrossRef
3.
go back to reference Hays, R. D., & Woolley, J. M. (2000). Nov the concept of clinically meaningful difference in health-related quality-of-life research. How meaningful is it? Pharmacoeconomics, 18(5), 419–423.PubMedCrossRef Hays, R. D., & Woolley, J. M. (2000). Nov the concept of clinically meaningful difference in health-related quality-of-life research. How meaningful is it? Pharmacoeconomics, 18(5), 419–423.PubMedCrossRef
5.
go back to reference Duh, M. S., Lefebvre, P., Fastenau, J., Piech, C. T., & Waltzman, R. J. (2005). Assessing the clinical benefits of erythropoietic agents using area under the hemoglobin change curve. Oncologist, 10(6), 438–448.PubMedCrossRef Duh, M. S., Lefebvre, P., Fastenau, J., Piech, C. T., & Waltzman, R. J. (2005). Assessing the clinical benefits of erythropoietic agents using area under the hemoglobin change curve. Oncologist, 10(6), 438–448.PubMedCrossRef
6.
go back to reference Lydick, E., Epstein, R. S., Himmelberger, D., & White, C. J. (1995). Area under the curve: A metric for patient subjective responses in episodic diseases. Quality of Life Research, 4(1), 41–45.PubMedCrossRef Lydick, E., Epstein, R. S., Himmelberger, D., & White, C. J. (1995). Area under the curve: A metric for patient subjective responses in episodic diseases. Quality of Life Research, 4(1), 41–45.PubMedCrossRef
7.
go back to reference Raskin, P., Klaff, L., McGill, J., South, S. A., Hollander, P., Khutoryansky, N., et al. (2003). Efficacy and safety of combination therapy: Repaglinide plus metformin versus nateglinide plus metformin. Diabetes Care, 26(7), 2063–2068.PubMedCrossRef Raskin, P., Klaff, L., McGill, J., South, S. A., Hollander, P., Khutoryansky, N., et al. (2003). Efficacy and safety of combination therapy: Repaglinide plus metformin versus nateglinide plus metformin. Diabetes Care, 26(7), 2063–2068.PubMedCrossRef
8.
go back to reference Barden, J., Edwards, J., Moore, R. A., McQuay, H. J. (2004). Single dose oral diclofenac for postoperative pain. Cochrane database of systematic reviews, 2, CD004768. Barden, J., Edwards, J., Moore, R. A., McQuay, H. J. (2004). Single dose oral diclofenac for postoperative pain. Cochrane database of systematic reviews, 2, CD004768.
9.
go back to reference Toms, L., McQuay, H. J., Derry, S., Moore, R. A. (2008). Single dose oral paracetamol (acetaminophen) for postoperative pain in adults. Cochrane database of systematic reviews, 4, CD004602. Toms, L., McQuay, H. J., Derry, S., Moore, R. A. (2008). Single dose oral paracetamol (acetaminophen) for postoperative pain in adults. Cochrane database of systematic reviews, 4, CD004602.
10.
go back to reference Cappelleri, J. C., Bushmakin, A. G., Zlateva, G., & Sadosky, A. (2009). Pain responder analysis: Use of area under the curve to enhance interpretation of clinical trial results. Pain Practice, 9(5), 348–353.PubMedCrossRef Cappelleri, J. C., Bushmakin, A. G., Zlateva, G., & Sadosky, A. (2009). Pain responder analysis: Use of area under the curve to enhance interpretation of clinical trial results. Pain Practice, 9(5), 348–353.PubMedCrossRef
11.
go back to reference Wolfe, F., Smythe, H. A., Yunus, M. B., Bennett, R. M., Bombardier, C., Goldenberg, D. L., et al. (1990). The American college of rheumatology 1990 criteria for the classification of fibromyalgia. Arthritis Rheumatism, 33(2), 160–172.PubMedCrossRef Wolfe, F., Smythe, H. A., Yunus, M. B., Bennett, R. M., Bombardier, C., Goldenberg, D. L., et al. (1990). The American college of rheumatology 1990 criteria for the classification of fibromyalgia. Arthritis Rheumatism, 33(2), 160–172.PubMedCrossRef
12.
go back to reference Arnold, L. M., Russell, I. J., Diri, E. W., Duan, W. R., Young, J. P., Jr, Sharma, U., et al. (2008). A 14 week, randomized, double-blind, placebo-controlled monotherapy trial of pregabalin in patients with fibromyalgia. Journal Pain, 9(9), 792–805.CrossRef Arnold, L. M., Russell, I. J., Diri, E. W., Duan, W. R., Young, J. P., Jr, Sharma, U., et al. (2008). A 14 week, randomized, double-blind, placebo-controlled monotherapy trial of pregabalin in patients with fibromyalgia. Journal Pain, 9(9), 792–805.CrossRef
13.
go back to reference Russell, I. J., Crofford, L. J., Leon, T., Cappelleri, J. C., Bushmakin, A. G., Whalen, E., et al. (2009). The effects of pregabalin on sleep disturbance symptoms among individuals with fibromyalgia syndrome. Sleep Medicine, 10(6), 604–610.PubMedCrossRef Russell, I. J., Crofford, L. J., Leon, T., Cappelleri, J. C., Bushmakin, A. G., Whalen, E., et al. (2009). The effects of pregabalin on sleep disturbance symptoms among individuals with fibromyalgia syndrome. Sleep Medicine, 10(6), 604–610.PubMedCrossRef
14.
go back to reference Cappelleri, J. C., Bushmakin, A. G., McDermott, A. M., Sadosky, A. B., Petrie, C. D., & Martin, S. (2009). Psychometric properties of a single-item scale to assess sleep quality among individuals with fibromyalgia. Health Quality Life Outcomes, 7, 54–60.CrossRef Cappelleri, J. C., Bushmakin, A. G., McDermott, A. M., Sadosky, A. B., Petrie, C. D., & Martin, S. (2009). Psychometric properties of a single-item scale to assess sleep quality among individuals with fibromyalgia. Health Quality Life Outcomes, 7, 54–60.CrossRef
15.
go back to reference Mease, P. J., Arnold, L. M., Crofford, L. J., Williams, D. A., Russell, I. J., Humphrey, L., et al. (2008). Identifying the clinical domains of fibromyalgia: Contributions from the clinician and patient Delphi exercises. Arthritis Rheumatism, 59(7), 952–960.PubMedCrossRef Mease, P. J., Arnold, L. M., Crofford, L. J., Williams, D. A., Russell, I. J., Humphrey, L., et al. (2008). Identifying the clinical domains of fibromyalgia: Contributions from the clinician and patient Delphi exercises. Arthritis Rheumatism, 59(7), 952–960.PubMedCrossRef
16.
go back to reference Martin, S., Chandran, A., Zografos, L., & Zlateva, G. (2009). Evaluation of the impact of fibromyalgia on patients’ sleep and the content validity of two sleep scales. Health Quality Life Outcomes, 7, 64–70.CrossRef Martin, S., Chandran, A., Zografos, L., & Zlateva, G. (2009). Evaluation of the impact of fibromyalgia on patients’ sleep and the content validity of two sleep scales. Health Quality Life Outcomes, 7, 64–70.CrossRef
17.
go back to reference Farrar, J. T., Dworkin, R. H., & Max, M. B. (2006). Use of the cumulative proportion of responders analysis graph to present pain data over a range of cut-off points: Making clinical trial data more understandable. Journal Pain Symptom Management, 31(4), 369–377.CrossRef Farrar, J. T., Dworkin, R. H., & Max, M. B. (2006). Use of the cumulative proportion of responders analysis graph to present pain data over a range of cut-off points: Making clinical trial data more understandable. Journal Pain Symptom Management, 31(4), 369–377.CrossRef
18.
go back to reference Fairclough, D. L. (2010). Design and analysis of quality of life studies in clinical trials (2nd ed.). Boca Raton, FL: Chapman and Hall/CRC.CrossRef Fairclough, D. L. (2010). Design and analysis of quality of life studies in clinical trials (2nd ed.). Boca Raton, FL: Chapman and Hall/CRC.CrossRef
19.
go back to reference Elfron, B., & Tibshirani, R. J. (1993). An introduction to the bootstrap. Boca Raton, FL: Chapman and Hall/CRC. Elfron, B., & Tibshirani, R. J. (1993). An introduction to the bootstrap. Boca Raton, FL: Chapman and Hall/CRC.
20.
go back to reference SAS Institute. (2008). SAS/STAT ® 9.2 User’s Guide. Cary, NC: SAS Institute Inc. SAS Institute. (2008). SAS/STAT ® 9.2 User’s Guide. Cary, NC: SAS Institute Inc.
21.
go back to reference Farrar, J. T., Young, J. P., Jr, LaMoreaux, L., Werth, J. L., & Poole, R. M. (2001). Nov clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale. Pain, 94(2), 149–158.PubMedCrossRef Farrar, J. T., Young, J. P., Jr, LaMoreaux, L., Werth, J. L., & Poole, R. M. (2001). Nov clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale. Pain, 94(2), 149–158.PubMedCrossRef
22.
go back to reference Snapinn, S. M., & Jiang, Q. (2007). Responder analyses and the assessment of a clinically relevant treatment effect. Trials, 8, 31.PubMedCrossRef Snapinn, S. M., & Jiang, Q. (2007). Responder analyses and the assessment of a clinically relevant treatment effect. Trials, 8, 31.PubMedCrossRef
Metagegevens
Titel
Applying area-under-the-curve analysis to enhance interpretation of response profiles: an application to sleep quality scores in patients with fibromyalgia
Auteurs
Andrew G. Bushmakin
Joseph C. Cappelleri
Gergana Zlateva
Alesia Sadosky
Publicatiedatum
01-05-2011
Uitgeverij
Springer Netherlands
Gepubliceerd in
Quality of Life Research / Uitgave 4/2011
Print ISSN: 0962-9343
Elektronisch ISSN: 1573-2649
DOI
https://doi.org/10.1007/s11136-010-9776-4

Andere artikelen Uitgave 4/2011

Quality of Life Research 4/2011 Naar de uitgave